Xeris Pharmaceuticals Inc (NASDAQ:XERS) — Market Cap & Net Worth

$1.40 Billion USD · Rank #7510

Market Cap & Net Worth: Xeris Pharmaceuticals Inc (XERS)

Xeris Pharmaceuticals Inc (NASDAQ:XERS) has a market capitalization of $1.40 Billion ($1.40 Billion) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7510 globally and #2266 in its home market, demonstrating a -8.25% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xeris Pharmaceuticals Inc's stock price $7.78 by its total outstanding shares 182320306 (182.32 Million). Also see total assets of Xeris Pharmaceuticals Inc for a full breakdown of the balance sheet.

Xeris Pharmaceuticals Inc Market Cap History: 2018 to 2026

Xeris Pharmaceuticals Inc's market capitalization history from 2018 to 2026. Data shows change from $3.10 Billion to $1.42 Billion (-10.94% CAGR). Also see Xeris Pharmaceuticals Inc (XERS) cash flow conversion for how efficiently the company converts equity into cash flow.

Index Memberships

Xeris Pharmaceuticals Inc is a constituent of 3 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.66 Trillion	0.05%	#218 of 976
NASDAQ Composite IXIC	$41.69 Trillion	0.00%	#832 of 3165
NASDAQ Biotechnology NBI	$1.88 Trillion	0.07%	#126 of 263

Weight: Xeris Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Xeris Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Xeris Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check XERS stock price and chart for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

4.90x

Xeris Pharmaceuticals Inc's market cap is 4.90 times its annual revenue

Industry average: 0.57x Higher than industry average

Latest Price to Earnings (P/E) Ratio

2583.42x

Xeris Pharmaceuticals Inc's market cap is 2583.42 times its annual earnings

Industry average: 2.01x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2018	$3.10 Billion	$2.46 Million	-$60.08 Million	1257.38x	N/A
2019	$1.29 Billion	$2.72 Million	-$125.58 Million	472.21x	N/A
2020	$897.02 Million	$2.72 Million	-$125.58 Million	329.54x	N/A
2021	$534.20 Million	$49.59 Million	-$122.72 Million	10.77x	N/A
2022	$242.49 Million	$110.25 Million	-$94.66 Million	2.20x	N/A
2023	$428.45 Million	$163.91 Million	-$62.26 Million	2.61x	N/A
2024	$618.07 Million	$203.07 Million	-$54.84 Million	3.04x	N/A
2025	$1.43 Billion	$291.85 Million	$554.00K	4.90x	2583.42x

Competitor Companies of XERS by Market Capitalization

Companies near Xeris Pharmaceuticals Inc in the global market cap rankings as of September 18, 2026. Review Xeris Pharmaceuticals Inc tangible equity quality to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Xeris Pharmaceuticals Inc by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #519 globally with a market cap of $52.60 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #640 globally with a market cap of $43.16 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.62 Billion USD ( CN¥277.61 Billion CNY).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#519	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#633	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.00
#640	GALDERMA GROUP AG	NYSE:GALDY	$43.16 Billion	$37.02
#670	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$40.62 Billion	CN¥43.52

Xeris Pharmaceuticals Inc Historical Marketcap From 2018 to 2026

Between 2018 and today, Xeris Pharmaceuticals Inc's market cap moved from $3.10 Billion to $ 1.42 Billion, with a yearly change of -10.94%.

Year	Market Cap	Change (%)
2026	$1.42 Billion	-0.89%
2025	$1.43 Billion	+131.56%
2024	$618.07 Million	+44.26%
2023	$428.45 Million	+76.69%
2022	$242.49 Million	-54.61%
2021	$534.20 Million	-40.45%
2020	$897.02 Million	-30.21%
2019	$1.29 Billion	-58.53%
2018	$3.10 Billion	--

End of Day Market Cap According to Different Sources

On Sep 17th, 2026 the market cap of Xeris Pharmaceuticals Inc was reported to be:

Source	Market Cap
Yahoo Finance	$1.40 Billion USD
MoneyControl	$1.40 Billion USD
MarketWatch	$1.40 Billion USD
marketcap.company	$1.40 Billion USD
Reuters	$1.40 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Xeris Pharmaceuticals Inc

NASDAQ:XERS USA Drug Manufacturers - Specialty & Generic

Market Cap

$1.42 Billion

Market Cap Rank

#7510 Global

#2266 in USA

Share Price

$7.78

Change (1 day)

+3.87%

52-Week Range

$5.29 - $9.90

All Time High

$27.23